pharmaceuticals-and-healthcare

Global Liraglutide Market Insights, Forecast to 2025


Published On : Oct 2018

Category : Pharmaceutical

No. of Pages : 117 pages

  • $3900
  • $7800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the global market size of Liraglutide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Liraglutide in these regions.
This research report categorizes the global Liraglutide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.
In these patents, accounting for Europe is the largest, followed by North America, and finally Asia.
The application of Liraglutide
Liraglutide for the treatment of type 2 diabetes mellitus
Liraglutide 1.2 mg daily in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedione) is recommended as an option for the treatment of people with type 2 diabetes, only if used as described for exenatide in 'Type 2 diabetes: the management of type 2 diabetes'
Liraglutide 1.2 mg daily in dual therapy regimens (in combination with metformin or a sulphonylurea) is recommended as an option for the treatment of people with type 2 diabetes, only if the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and the person is intolerant of thiazolidinediones and dipeptidyl peptidase-4 (DPP-4) inhibitors, or treatment with thiazolidinediones and DPP-4 inhibitors is contraindicated.
Liraglutide 1.8 mg daily is not recommended for the treatment of people with type 2 diabetes.
The Committee concluded that the evidence provided was not robust enough to allow it to recommend liraglutide as a cost-effective alternative to either thiazolidinediones or DPP-4 inhibitors as a triple therapy regimen, however it believes liraglutide is a cost-effective treatment option relative to exenatide.

Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.
The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.

In 2017, the global Liraglutide market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Liraglutide market based on company, product type, application and key regions.

The various contributors involved in the value chain of Liraglutide include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Liraglutide include
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm

Market Size Split by Type
Pills
Liquid
Market Size Split by Application
Hospital
Drug Store

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Liraglutide market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Liraglutide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Liraglutide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Liraglutide with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Liraglutide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Liraglutide are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Liraglutide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

In the recent times, the global market for Global liraglutide market insights forecast to 2025 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global liraglutide market insights forecast to 2025 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global liraglutide market insights forecast to 2025 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global liraglutide market insights forecast to 2025 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global liraglutide market insights forecast to 2025 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global liraglutide market insights forecast to 2025, including the definition, classification, and industry chain structure of Global liraglutide market insights forecast to 2025, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global liraglutide market insights forecast to 2025.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global liraglutide market insights forecast to 2025 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global liraglutide market insights forecast to 2025, implemented in each of the geographical segments. The predominant applications of the Global liraglutide market insights forecast to 2025 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global liraglutide market insights forecast to 2025 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global liraglutide market insights forecast to 2025 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Liraglutide
Figure Global Liraglutide Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Liraglutide Production Market Share by Types (Product Category) in 2017
Figure Pills Product Picture
Table Major Manufacturers of Pills
Figure Liquid Product Picture
Table Major Manufacturers of Liquid
Table Global Liraglutide Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospital
Figure Drug Store
Figure Liraglutide Report Years Considered
Figure Global Liraglutide Market Size 2016-2025 (Million US$)
Figure Global Liraglutide Sales 2016-2025 (K Units)
Table Global Liraglutide Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Liraglutide Sales by Regions 2016-2025 (K Units)
Table Global Liraglutide Sales Market Share by Regions 2016-2025
Figure Global Liraglutide Sales Market Share by Regions 2016-2025
Figure 2017 Global Liraglutide Sales Market Share by Regions
Table Global Liraglutide Revenue by Regions 2016-2025 (Million US$)
Table Global Liraglutide Revenue Market Share by Regions 2016-2025
Figure Global Liraglutide Revenue Market Share by Regions 2016-2025
Figure 2017 Global Liraglutide Revenue Market Share by Regions
Table Global Liraglutide Sales by Manufacturers (2016-2018) (K Units)
Table Global Liraglutide Sales Share by Manufacturers (2016-2018)
Figure Global Liraglutide Sales Share by Manufacturers in 2017
Table Liraglutide Revenue by Manufacturers (2016-2018) (Million US$)
Table Liraglutide Revenue Share by Manufacturers (2016-2018)
Figure Liraglutide Value Share by Manufacturers in 2017
Table Global Liraglutide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Liraglutide Price (2016-2018) (USD/Unit)
Table Liraglutide Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Liraglutide Product Category
Table Date of International Manufacturers Enter into Liraglutide Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Liraglutide Sales by Type (2016-2025) (K Units)
Table Global Liraglutide Sales Share by Type (2016-2025)
Figure Global Liraglutide Sales Market Share by Type (2016-2025)
Figure Global Liraglutide Sales Market Share by Type in 2017
Table Global Liraglutide Revenue by Type (2016-2025) (Million US$)
Table Global Liraglutide Revenue Share by Type (2016-2025)
Figure Global Liraglutide Revenue Market Share by Type (2016-2025)
Figure Global Liraglutide Revenue Market Share by Type in 2017
Table Liraglutide Price by Type 2013-2018 (USD/Unit)
Table Global Liraglutide Sales by Application (2016-2025) (K Units)
Table Global Liraglutide Sales Share by Application (2016-2025)
Figure Global Sales Liraglutide Market Share by Application (2016-2025)
Figure Global Sales Liraglutide Market Share by Application (2016-2025)
Figure North America Liraglutide Sales Growth Rate 2016-2025 (K Units)
Figure North America Liraglutide Revenue Growth Rate 2016-2025 (Million US$)
Table North America Liraglutide Sales by Countries (2016-2025) (K Units)
Table North America Liraglutide Sales Market Share by Countries (2016-2025)
Figure 2017 North America Liraglutide Sales Market Share by Countries
Table North America Liraglutide Revenue by Countries (2016-2025) (Million US$)
Table North America Liraglutide Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Liraglutide Revenue Market Share by Countries
Figure United States Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure United States Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Canada Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Table North America Liraglutide Sales by Type (2016-2025) (K Units)
Table North America Liraglutide Sales Market Share by Type (2016-2025)
Figure 2017 North America Liraglutide Market Share by Type
Table North America Liraglutide Sales by Application (2016-2025) (K Units)
Table North America Liraglutide Sales Market Share by Application (2016-2025)
Figure 2017 North America Liraglutide Market Share by Application
Table North America Liraglutide Sales by Company (2016-2018) (K Units)
Table North America Liraglutide Sales Market Share by Company (2016-2018)
Figure North America Liraglutide Sales Market Share by Company in 2017
Figure Europe Liraglutide Sales Growth Rate 2016-2025 (K Units)
Figure Europe Liraglutide Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Liraglutide Sales by Countries (2016-2025) (K Units)
Table Europe Liraglutide Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Liraglutide Sales Market Share by Countries
Table Europe Liraglutide Revenue by Countries (2016-2025) (Million US$)
Table Europe Liraglutide Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Liraglutide Revenue Market Share by Countries
Figure Germany Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Germany Liraglutide Revenue Growth Rate (2016-2025) (K Units)
Figure France Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure France Liraglutide Revenue Growth Rate (2016-2025) (K Units)
Figure UK Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure UK Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Italy Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Russia Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Liraglutide Sales by Type (2016-2025) (K Units)
Table Europe Liraglutide Sales Market Share by Type (2016-2025)
Figure 2017 Europe Liraglutide Market Share by Type
Table Europe Liraglutide Sales by Application (2016-2025) (K Units)
Table Europe Liraglutide Sales Market Share by Application (2016-2025)
Figure 2017 Europe Liraglutide Market Share by Application
Table Europe Liraglutide Sales by Company (2016-2018) (K Units)
Table Europe Liraglutide Sales Market Share by Company (2016-2018)
Figure Europe Liraglutide Sales Market Share by Company in 2017
Figure Asia Pacific Liraglutide Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Liraglutide Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Liraglutide Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Liraglutide Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Liraglutide Sales Market Share by Countries
Table Asia Pacific Liraglutide Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Liraglutide Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Liraglutide Revenue Market Share by Countries
Figure China Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure China Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Japan Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Korea Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure India Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure India Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Australia Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Liraglutide Sales by Type (2016-2025) (K Units)
Table Asia Pacific Liraglutide Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Liraglutide Market Share by Type
Table Asia Pacific Liraglutide Sales by Application (2016-2025) (K Units)
Table Asia Pacific Liraglutide Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Liraglutide Market Share by Application
Table Asia Pacific Liraglutide Sales by Company (2016-2018) (K Units)
Table Asia Pacific Liraglutide Sales Market Share by Company (2016-2018)
Figure Asia Pacific Liraglutide Sales Market Share by Company in 2017
Figure Central & South America Liraglutide Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Liraglutide Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Liraglutide Sales by Countries (2016-2025) (K Units)
Table Central & South America Liraglutide Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Liraglutide Sales Market Share by Countries
Table Central & South America Liraglutide Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Liraglutide Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Liraglutide Revenue Market Share by Countries
Figure Brazil Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Liraglutide Sales by Type (2016-2025) (K Units)
Table Central & South America Liraglutide Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Liraglutide Market Share by Type
Table Central & South America Liraglutide Sales by Application (2016-2025) (K Units)
Table Central & South America Liraglutide Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Liraglutide Market Share by Application
Table Central & South America Liraglutide Sales by Company (2016-2018) (K Units)
Table Central & South America Liraglutide Sales Market Share by Company (2016-2018)
Figure Central & South America Liraglutide Sales Market Share by Company in 2017
Figure Middle East and Africa Liraglutide Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Liraglutide Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Liraglutide Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Liraglutide Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Liraglutide Sales Market Share by Countries
Table Middle East and Africa Liraglutide Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Liraglutide Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Liraglutide Revenue Market Share by Countries
Figure GCC Countries Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Liraglutide Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Liraglutide Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Liraglutide Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Liraglutide Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Liraglutide Market Share by Type
Table Middle East and Africa Liraglutide Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Liraglutide Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Liraglutide Market Share by Application
Table Middle East and Africa Liraglutide Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Liraglutide Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Liraglutide Sales Market Share by Company in 2017
Table HEC Pharm Company Details
Table HEC Pharm Liraglutide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table HEC Pharm Recent Development
Table Bachem Company Details
Table Bachem Liraglutide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bachem Recent Development
Table Bharat Pharmaceuticals Company Details
Table Bharat Pharmaceuticals Liraglutide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bharat Pharmaceuticals Recent Development
Table Kingpep Biotechnology Company Details
Table Kingpep Biotechnology Liraglutide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Kingpep Biotechnology Recent Development
Table Shenzhen JYMed Technology Company Details
Table Shenzhen JYMed Technology Liraglutide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Shenzhen JYMed Technology Recent Development
Table Wuxi Asiapeptide Company Details
Table Wuxi Asiapeptide Liraglutide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Wuxi Asiapeptide Recent Development
Table AmbioPharm Company Details
Table AmbioPharm Liraglutide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table AmbioPharm Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Liraglutide Value Chain
Table Typical Suppliers of Key Liraglutide Raw Material
Table Liraglutide Customers List
Table Liraglutide Sales Channels
Table Liraglutide Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top